Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System An evaluation of the safety and performance of the STANZA Drug-eluting Resorbable Scaffold (DRS) system for the treatment of patients with obstructive superficial femoral artery disease.

• Country None
• organs None
• Specialty None

Pharmacokinetic Study of Drug-coated Angioplasty Balloons in the Superficial Femoral or Popliteal Arteries: To describe the pharmacokinetics of paclitaxel in the blood delivered from a paclitaxel coated percutaneous angioplasty balloon catheter as a result of treatment of de novo or restenotic l...

• Country None
• organs None
• Specialty None

EMBA Peripheral Embolization Device ("EPED") Study This is an open label, acute, non-randomized, prospective, "first in man" (FIM) single-center study of the EMBA Medical Peripheral Embolization Device (PED).

• Country None
• organs None
• Specialty None

Zilver PTX Delivery System The objective of this study is to evaluate the performance of the Zilver PTX stent thumbwheel delivery system.

• Country Australia, Germany, New Zealand
• organs None
• Specialty None

Safety and Feasibility Study of the Shockwave Lithoplasty System To study the early safety and performance of the Shockwave Medical System in subjects to demonstrate that the device can safely and effectively deliver localized energy for the treatment o...

• Country New Zealand
• organs None
• Specialty None

PQ Bypass Guide Wire Delivery System for Femoropopliteal Bypass To assess the safety of performing a percutaneous fem-pop bypass using the PQ Bypass Guidewire Delivery System and commercially available stent grafts.

• Country New Zealand
• organs None
• Specialty None

Aorfix Intelliflex First in Human Study The First In Human (FIH) study is a long-term, single center, non-randomized study established by Lombard Medical, Inc. to collect "on-label" data in the clinical setting on patients under...

• Country None
• organs None
• Specialty None